Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955045 · ClinicalTrials.gov registry record · Phase 2
A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy
A Phase 2 study, sponsored by Kyowa Kirin.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00955045: Completed Phase 2 study, sponsored by Kyowa Kirin.
NCT00955045 is a Phase 2 study that has completed, run by Kyowa Kirin. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00955045, a Phase 2 study, has completed, sponsored by Kyowa Kirin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The primary objective of this study was to establish the long-term tolerability and safety of istradefylline treatment in subjects with Parkinson's disease treated with levodopa/carbidopa. In addition, treatment response and maintenance of response were assessed.
Interventions
- DRUG istradefylline
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-08 |
| Est. Completion | 2003-10 |
| Phase | Phase 2 |
What the finished NCT00955045 record still lists
NCT00955045 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which istradefylline is the first listed.
NCT00955045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00955045 about?
NCT00955045 is a clinical study titled "A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy". The primary objective of this study was to establish the long-term tolerability and safety of istradefylline treatment in subjects with Parkinson's disease treated with levodopa/carbidopa. In addition, treatment response and maintenance of response were assessed.
What is the current status of trial NCT00955045?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-08. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00955045?
The interventions under investigation include: istradefylline (DRUG).
Who is sponsoring clinical trial NCT00955045?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia